Evidence map›Paper›PMID 31465214›Full record

ArticleACS synthetic biology2019

Developing a Versatile Shotgun Cloning Strategy for Single-Vector-Based Multiplex Expression of Short Interfering RNAs (siRNAs) in Mammalian Cells.

Xi Wang, Chengfu Yuan, Bo Huang, Jiaming Fan, Yixiao Feng, Alexander J Li, Bo Zhang, Yan Lei, Zhenyu Ye, Ling Zhao and 18 more

Open access · hybridAbstract read
In one paragraph

Article in ACS synthetic biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Current Advances in Adeno-Associated Virus-Mediated Gene Therapy to Prevent Acquired Hearing Loss.Journal of the Association for Research in Otolaryngology : JARO · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 8 institutions in 2 countries.

Xi WangMinistry of Education Key Laboratory of Diagnostic Medicine, and School of Laboratory and Diagnostic Medicine , Chongqing Medical University , Chongqing , 400016 , China.
Chengfu YuanMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Bo HuangMinistry of Education Key Laboratory of Diagnostic Medicine, and School of Laboratory and Diagnostic Medicine , Chongqing Medical University , Chongqing , 400016 , China.
Jiaming FanMinistry of Education Key Laboratory of Diagnostic Medicine, and School of Laboratory and Diagnostic Medicine , Chongqing Medical University , Chongqing , 400016 , China.
Yixiao FengMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Alexander J LiMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Bo ZhangMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Yan LeiMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Zhenyu YeMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Ling ZhaoMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Daigui CaoMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Lijuan YangMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Di WuMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Xian ChenMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Bin LiuMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
William WagstaffMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Fang HeMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Xiaoxing WuMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Huaxiu LuoMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Jing ZhangMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Meng ZhangMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Rex C HaydonMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Hue H LuuMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Michael J LeeMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Jennifer Moriatis WolfMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.
Ailong HuangKey Laboratory of Molecular Biology for Infectious Diseases of The Ministry of Education of China, Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital , Chongqing Medical University , Chongqing , China.
Tong-Chuan HeMolecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine , The University of Chicago Medical Center , Chicago , Illinois 60637 , United States.ORCID 0000-0001-7721-3934
Zongyue ZengMinistry of Education Key Laboratory of Diagnostic Medicine, and School of Laboratory and Diagnostic Medicine , Chongqing Medical University , Chongqing , 400016 , China.
University of Chicago Medical Center · USChina Three Gorges University · CNChongqing Medical University · CNNanchang University · CNQingdao University · CNSichuan University · CNSoochow University · CNSouthwest University · CN

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI MARK W. LINGEN · 1985 to 2026
$122.1M
Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
A genomewide discovery of chemoresistance-associated noncoding RNAs in human cancersR21CA226303 · NCI · UNIVERSITY OF CHICAGO · PI HE, TONG-CHUAN · 2018 to 2019
$381k
NCATS NIH HHS UL1 TR000430NCI NIH HHS P30 CA014599NCI NIH HHS R21 CA226303
6 · The paper itself

Abstract

As an important post-transcriptional regulatory machinery mediated by ∼21nt short-interfering double-stranded RNA (siRNA), RNA interference (RNAi) is a powerful tool to delineate gene functions and develop therapeutics. However, effective RNAi-mediated silencing requires multiple siRNAs for given genes, a time-consuming process to accomplish. Here, we developed a user-friendly system for single-vector-based multiplex siRNA expression by exploiting the unique feature of restriction endonuclease BstXI. Specifically, we engineered a BstXI-based shotgun cloning (BSG) system, which consists of three entry vectors with siRNA expression units (SiEUs) flanked with distinct BstXI sites, and a retroviral destination vector for shotgun SiEU assembly. For proof-of-principle studies, we constructed multiplex siRNA vectors silencing β-catenin and/or Smad4 and assessed their functionalities in mesenchymal stem cells (MSCs). Pooled siRNA cassettes were effectively inserted into respective entry vectors in one-step, and shotgun seamless assembly of pooled BstXI-digested SiEU fragments into a retroviral destination vector followed. We found these multiplex siRNAs effectively silenced β-catenin and/or Smad4, and inhibited Wnt3A- or BMP9-specific reporters and downstream target expression in MSCs. Furthermore, multiplex silencing of β-catenin and/or Smad4 diminished Wnt3A and/or BMP9-induced osteogenic differentiation. Collectively, the BSG system is a user-friendly technology for single-vector-based multiplex siRNA expression to study gene functions and develop experimental therapeutics.

Indexed as

RNA InterferenceAnimalsbeta CateninCell DifferentiationCell LineCloning, MolecularGenetic VectorsGrowth Differentiation Factor 2Mesenchymal Stem CellsMiceOsteogenesisRNA, Small InterferingSmad4 ProteinWnt Signaling Pathwaybeta CateninGrowth Differentiation Factor 2RNA, Small InterferingSmad4 ProteinBMP9/Smad4 signalingmesenchymal stem cells (MSCs)multiplex expressionosteogenic differentiationRNA interference (RNAi)short interfering double-stranded RNA (siRNA)shotgun cloningWnt/β-catenin signaling

Identifiers

PMID31465214
PMCPMC6760290
OpenAlexW2971075949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.